Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04593264 · ClinicalTrials.gov registry record · NA

Quantifying the Benefits of Supervised vs. Unsupervised Pre-habilitation for Patients With Acute ACL Tears

A NA study, sponsored by WellSpan Health.

Completed
Registry status
NA
Development phase
128
Enrollment target

NCT04593264: Completed NA study, sponsored by WellSpan Health.

NCT04593264 is a NA study that has completed, run by WellSpan Health. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04593264, a NA study, has completed, sponsored by WellSpan Health.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target

Study Summary

Although the success of physical therapy following surgery has been well-documented and validated in patients undergoing Anterior Cruciate Ligament Reconstruction (ACLR) procedures, more recent studies have demonstrated that patient outcomes are the most favorable when surgery is delayed approximately 4 weeks until after the patient has completed a preoperative physical therapy program, or "pre-habilitation." The ultimate goal of pre-habilitation is to regain full range of motion in the knee and reach approximately 80% of pre-injury quadricep strength. However, extra physical therapy can stress both time and resources. Thus, we propose a home-based, self-guided pre-habilitation program. We hypothesize that patients participating in self-guided pre-habilitation will experience the same benefits as patients in a traditional office-based physical therapy program.

Primary Outcome

The surgeon will decide if the patient's knee is optimized and ready for surgery based on quadricep circumference and range of motion.

Interventions

  • OTHER Self-guided pre-habilitation exercise program
  • OTHER Traditional pre-habilitation

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2021-02-23
Est. Completion 2022-06-30
Phase NA
WellSpan Health

21 total trials

What the finished NCT04593264 record still lists

NCT04593264 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Self-guided pre-habilitation exercise program is the first listed.

NCT04593264 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04593264 about?

NCT04593264 is a clinical study titled "Quantifying the Benefits of Supervised vs. Unsupervised Pre-habilitation for Patients With Acute ACL Tears". Although the success of physical therapy following surgery has been well-documented and validated in patients undergoing Anterior Cruciate Ligament Reconstruction (ACLR) procedures, more recent studies have demonstrated that patient outcomes are the most favorable when surgery is delayed approximate...

What is the current status of trial NCT04593264?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2021-02-23. Estimated completion is 2022-06-30.

What interventions are being tested in trial NCT04593264?

The interventions under investigation include: Self-guided pre-habilitation exercise program (OTHER), Traditional pre-habilitation (OTHER).

Who is sponsoring clinical trial NCT04593264?

This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04593264's enrollment target sits among peer trials

128 744th of 2000 higher than 1,252 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04593264, the US trial registry maintained by the National Library of Medicine. NCT04593264 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.